## Daily Biotech / Pharma Headlines ### Top Stories - **[FDA clears Travere's Filspari for FSGS](https://www.biopharmadive.com/news/travere-fda-approve-flispari-fsgs-kidney-disease/817415/)** — BioPharma Dive (3 sources) - **[FDA drafts genome-editing safety guidance](http://www.fda.gov/news-events/press-announcements/fda-issues-draft-guidance-genome-editing-safety-standards-advance-gene-therapy-development)** — FDA - **[Biotech offerings add up to $1.5B](https://endpoints.news/revolution-medicines-leads-latest-wave-of-stock-offerings-totaling-1-5b/)** — Endpoints News ### Regulatory & FDA - [FDA orders overdue trial disclosures](https://www.biospace.com/fda/fda-asks-2-200-drug-developers-to-make-trial-results-public-ramping-up-transparency-push) — BioSpace FDA - [MHRA clears high-dose Wegovy pen](https://www.gov.uk/government/news/single-dose-72mg-semaglutide-wegovy-pen-approved-to-treat-adult-patients-with-obesity) — MHRA ### Clinical & Research - [Parker Institute backs cancer vaccine push](https://endpoints.news/parker-institute-doubles-down-on-cancer-vaccines-as-part-of-ongoing-reboot/) — Endpoints News - [BioNTech ADC posts mid-stage efficacy](https://www.biospace.com/drug-development/biontech-dualitybio-tout-clinically-meaningful-efficacy-for-adc-in-mid-stage-endometrial-cancer-trial) — BioSpace Drug Development - [Spyre IBD drug shows early promise](https://www.biopharmadive.com/news/spyre-inflammatory-bowel-disease-drug-results-a4b7/817298/) — BioPharma Dive ### Deals & Finance - [Lilly buys CrossBridge Bio for ADCs](https://www.biopharmadive.com/news/lilly-crossbridge-acquire-deal-antibody-drug-conjugates/817421/) — BioPharma Dive (3 sources) - [Kailera targets $533M obesity IPO](https://www.biospace.com/business/kailera-eyes-record-533m-ipo-to-play-in-competitive-obesity-space-with-chinese-drugs) — BioSpace Business ### Company News - [J&J beats Stelara erosion in Q1](https://www.biopharmadive.com/news/johnson-johnson-2026-q1-earnings-stelara-tremfya-myeloma/817422/) — BioPharma Dive - [Lilly scales for oral GLP-1](https://www.biospace.com/business/lilly-investing-billions-to-prepare-for-overseas-oral-glp-1-launches) — BioSpace Business - [Click cuts staff after fundraise](https://endpoints.news/click-therapeutics-cuts-27-of-workforce-after-50m-raise/) — Endpoints News ### Policy & Politics - [Maryland sets first drug price cap](https://www.statnews.com/pharmalot/2026/04/13/maryland-affordability-board-sets-first-price-cap-diabetes-medicine/?utm_campaign=rss) — STAT Pharma
Daily Biotech / Pharma Headlines
Top Stories
Regulatory & FDA
Clinical & Research
Deals & Finance
Company News
Policy & Politics